Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001081346 | SCV000253561 | likely benign | Multiple endocrine neoplasia, type 2 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000572176 | SCV000674802 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000679730 | SCV000807025 | likely benign | not provided | 2018-01-24 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988345 | SCV001138028 | likely benign | Multiple endocrine neoplasia type 2A | 2019-05-28 | criteria provided, single submitter | clinical testing |